The IRIS device is FDA approved and designed to quickly transmit images to a bank for ophthalmologists to look for signs of vision impairment caused by diabetes, heart disease and other pathologies, according to the report. The device can be used in clinics and healthcare departments.
Dr. Gupta also serves as founder and chief medical officer for IRIS and chairman of the Pensacola, Fla.-based Retina Specialty Institute.
More Articles on Surgery Centers:
12 Statistics on Small ASC Gross Charges
ASC Ownership Sales: 4 Things to Consider Beforehand
10 Keys to Effective Internal ASC Claim Audits
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
